Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concerta and Strattera on Executive Function in ADHD Children
NCT01065259Phase 4Completed
- Sponsor
- Peking University
- Start
- Apr 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate, atomoxetine in attention deficit hyperactivity disorder (ADHD), sponsored by Peking University. Started Apr 2008; status: completed.
02
Drugs
methylphenidateatomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01065259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01065259.